TuttoCongressi
E-mail
Password
 Resta Collegato

Cerca per parole nell'archivio:
In archivio:
  • N° Relazioni: 792
  • N° Accessi Relaz.: 163804
Web Video
Portale Giovani Medici

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali Live Demo

   Mostra tutti | Mostra contenuti EasyRec   
26/02/2004
AUDITORIUM
08:00 - 10:00
OPENING LECTURE
C. Christiansen 
The management of osteporosis
10:20 - 12:20
SERMS: A MULTIPURPOSE TOOL IN THE MENAGEMENT OF MENOPAUSE
M. Gambacciani 
Raloxifene: a drug for bone quality and fracture prevention
A.M. Paoletti 
Raloxifene: a drug for uterus and genital tract therapy
P. Neven 
Raloxifene: effects on the breast
J. Calaf 
SERMs: a multipurpose tool in the management of osteoporosis
D. Agnusdei 
The future for raloxifene: a firework
12:30 - 13:00
PLENARY LECTURE
M.L. Brandi 
Estrogen receptor polymorphisms and women's health ande desease
14:00 - 16:00
DROSPIRENONE: MORE THAN A PROGESTOGEN - SPONSORED BY SCHERING
H. Rozenbaum 
Introduction
W. Oelkers 
Drospirenone: progestogen for contraception and HRT
G.A. MacGregor 
Aldosterone antagonist effects of drospirenone
JM. Foidart 
Benefits of drospirenone on water retention
C. Christiansen 
Effects of drospirenone/estrogen combinations on bone metabolism
16:10 - 16:40
PLENARY LECTURE
P.N. Barri 
Multiple pregnancies: an inevitable consequence of ART?
17:00 - 19:00
HRT AND FEMALE HEALTH: FROM RANDOMIZED CLINICAL TRIALS TO CLINICAL PRACTICE - SPONSORED BY ROTTAPHARM
C. Stevenson J 
HRT cardiovascular effects are dependent on regimen used (S1)
P. Maki 
Hormone therapy and cognitive function: is there a critical period for neuroprotection?
P. Sismondi 
Breast cancer and colon cancer
H. Rozenbaum 
Quality of life
L. Speroff 
A clinician's response tyo the WHI (S3)
 
P-AFFARI
10:20 - 12:00
AUTOCRINE, PARACRINE AND ENDOCRINE MECHANISMS OF OOCYTE AND EARLY EMBRYO DEVELOPMENT
PG. Artini 
Vascular endothelial growth factor in embryo endometrial interaction
Z. Ben-Rafael 
The inflammatory response during COH
12:30 - 13:00
PLENERY LECTURE
PL. Schenker 
Hyperprolactinemia and human reproduction
14:00 - 16:00
STEROIDS IN BRAIN REMODELLING AND PROTECTION
E.E. Baulieu 
Steroids in neurocells. Remodelling and function
F. Naftolin 
Estrogen, synaptic plasticity and hypothalamic reproductive aging
R. Diaz Brinton 
Progestin regulation of estrogen signaling in brain: crucial issues for hormone replacement therapy
M. Serio 
Hormonal control of antiapoptotic genes in human neurons
16:10 - 16:40
PLENARY LECTURE
Benninck PL Coellingh 
Esterol, the forgotten human fetal estrogen: an estrogen antagonist for the breast
17:00 - 19:00
PRE-TERM LABOUR AND DELIVERY
CJ. Lockwood 
Thrombin induces decidual protease and cyotkine expression in the pathogenesis of preterm membrane rupture associated with abruption
T. Laudanski 
Preterm labour: role of the myometrium
P. Florio 
Predective factors of preterm labour and delivery
M. Akerlund 
Preterm labour and delevery - therapy: the future
HJA Carp 
Role of thrombophilias in pregnancy and recurrent pregnancy loss
 
27/02/2004
AUDITORIUM
08:30 - 10:00
NEW STRATEGIES FOR POSTMENOPAUSAL OSTEOPOROSIS MANAGEMENT
G.B. Serra 
Recent advances for postmenopausal osteoporosis management
S. Adami 
Risedronate and osteoporosis treatment
M. Gambacciani 
Hormone replacement therapy for the prevention of osteoporosis in postmenopausal women
10:20 - 12:20
FROM FETAL DEVELOPMENT TO MENOPAUSE - SPONSORED BY SOLVAY
P.V. Nathanielsz 
The influence of early development: from fetus to menopause
F. Petraglia 
Endocrine and paracrine control of progesterone secretion during pregnancy
P. Van de Weijer 
Hormones and the patient and the media restoration of trust in our day-to-day practice (S14)
13:10 - 15:10
MILLION WOMEN'S STUDY
R. Gray 
HRT and breast cancer - a meta-analysis of clinical trials and epidemiological studies
J. Fiorica 
The role of progestins on the breast; information derived from the million women's study
S. Shapiro 
The million women's study. Potential biases do not allow a uncritical acceptance of the data
M. Whitehead 
The million women's study
15:10 - 17:10
MAMMOGRAPHIC DENSITY AND ITS IMPLICATIONS FOR THE INDIVIDUAL WOMAN'S HEALTH - SUPPORTED BY AN UNRESTRICTED GRANT FROM ORGANON
R. Santen 
Breast cancer and mammographic density
J. Eden 
The need for tissue selective menopausal agents
M.C. Pike 
The clinical view
M.J. Yaffe 
The radiological view
17:30 - 19:30
ORAL CONTRACEPTION: THE BEST CHOICE FOR FERTILE WOMAN - SPONSORED BY WYETH
J. Huber 
Sigmund Freud, Gustav Mahler, the pill and levonorgestrel
Martinez-Perez 
Loette: "evidence-based medicine in OC" the Spanish experience
A. Cagnacci 
Modern OC: the VTE controversy (VTE EMEA recommendation)
M. Primiero 
Worldwide Loette clinical experience and reasons for further regimens (continuos use LNG/EE)
 
P-AFFARI
10:20 - 12:20
STEROID RECEPTORS SIGNALING: MOLECULAR BASIS
T. Maruo 
Progesterone and SPRM in uterine leiomyoma growth and apoptosis
T. Simoncini 
New mechanisms for steroid hormone signalling
L. Devoto 
Steroidogenic acute regulatory protein (StAR) in the human corpus luteum
15:10 - 17:10
AMENORRHOEA: FROM DIAGNOSIS TO TREATMENT
S.L. Berga 
Neuroendocrine aspects of amenorrhea
M. Warren 
Amenorrhoea: from diagnosis to treatment
B. Mecekalski 
Functional hypothalamic amenorrhoea
17:30 - 19:30
ENDOCRINE ASPECTS OF ASSISTED REPRODUCTION
M. Szamatowicz 
Controlled ovarian hyperstimulation - the important step in ART. How to choose the best way of stimulation?
BC. Tarlatzis 
Ovarian stimulation and carcinogeneity
PC. Ho 
Oestradiol levels and endometrial receptivity
J. Dor 
Poor responders: can we improve the outcome?
 
28/02/2004
AUDITORIUM
08:30 - 10:00
METFORMING: A NEW CHALLENGE FOR POLYCYSTIC OVARY SINDROME - SPONSORED BY GUIDOTTI
A. Lanzone 
Glucose metabolism, insulin and ovarian androgens: what's the linkage
A.M. Fulghesu 
Adolescence and hyperinsulinemia: it is always the first step towords PCOS?
A.D. Genazzani 
Insulin-sensitizer metformin as direct/indirect modulator of the neuroendocrine control of gonadotropin secretion in hyperandrogenic women
J.E. Nestler 
Rationale and strategies for the use of metoformin to treat infertility in the polycystic ovary syndrome
10:10 - 10:40
PLENARY LECTURE
P. Kenemans 
Hormone replacement before and after breast cancer
14:00 - 14:30
PLENERY LECTURE - SPONSORED BY PFIZER
S. Caruso 
New prospectives in the managment of female sexual dysfunction: from pathophisiology to therapies
14:40 - 16:10
FROM OVULATION INDUCTION TO PREGNANCY MAINTENANCE - SPONSORED BY IBSA
L.G. Westergard 
Follicular fluid and serum levels of steroids and gonadotrophins in ART: relationships to st imulation protol and reproductive outcome
J.G. Grudzinska 
FSH: its measurement and administration in ART
G.F. Scarselli 
Progesterone and implantation
16:20 - 16:50
PLENARY LECTURE
G. Creatsas 
Disfunctional uterine bleeding during adolescence
 
P-AFFARI
08:30 - 10:00
LA VIA TRANSDERMICA REINVENTA LA CONTRACCEZIONE: GINECOLOGI E DONNE A CONFRONTO - SPONSORED BY JANSSEN-CILAG
Tavola rotonda 
(J. Baldaro Verde, V. Bruni, A.R. Genazzani, G.B. Melis)
11:00 - 13:00
ENDOMETRIOSIS
T.M. D' Hooghe 
PAthophysiology of endometriosis
V. Cela 
Endometriosis: diagnosis
A.E. Schindler 
Medical treatment of endometriosis
A. Luciano 
Role of GnRH-a in endometriosis
A. Wattiez 
Surgical treatment
14:00 - 14:30
PLENARY LECTURE
D. Purdie 
The oestrogens: pluripotent and polyvalent
14:40 - 16:10
PHYTOHORMONES: NEW SCIENTIFIC INSIGHTS IN EFFICACY AND SAFETY FOR WOMEN - SPONSORED BY NAMED
M. Imhof 
Do Phytohormones cause changes in genome activity?
J. Huber 
Nutrigenomics and Phytosteroids
T. Simoncini 
Vascular actions of red clover extracts
16:20 - 16:50
PLENARY LECTURE - SPONSORED BY SERVIER
P. Kenemans 
Why pulsed estrogen exposure results in better target tissue selectivity: a hypothesis (PL10)
17:20 - 19:20
GENOMICS AND PROTEOMICS IN GYNECOLOGICAL CANCERS
W. Wu 
Genomics and proteomics: new techniques in cancer research
P.M. Comoglio 
Post-genomic research unveils the genetic basis of invasive metastatic program
M.B. Daly 
Proteomic approaches to tumor markers discovery in ovarian cancer
A. Arcangeli 
 
VERDE
14:40 - 16:40
HORMONES AND CANCER
R.J. Santen 
Role of estrogenes in the development of breast cancer
J. Prat 
Hyperplasia and carcinoma of the endometrium
A. Gadducci 
Sex steroid hormones, gonadotropin and ovarian carcinogenesis: a review of epidemiological experimental data
F. Al-Azzawi 
Colon cancer
 
29/02/2004
AUDITORIUM
08:30 - 10:30
AGE-RELATED INFERTILITY AND OVARIAN FAILURE
V. Bruni 
Gonadal dysgenesis, from diagnosis to treatment
J. Studd 
Premature menopause - treatment
A. Lewin 
Physiopathology and treatment of age related female reproductive failure
A. Vujovic 
COLIA 1 gene polymorphism ovarian failure
11:00 - 13:00
THE POSTMENOPAUSAL WOMAN'S RISK: THE THERAPEUTIC DILEMMA
MJ. Mooren Van der 
HRT and cardiovascular health in PMW
A.R. Genazzani 
HRT and the central nervous system in PMW
O. Ylikorkala 
New SERMs, can they replace HRT?
P. Weijer Van der 
Seven years is a long time! The Heikkinen study: long term adherece to continuous combined hormone therapy
 
P-AFFARI
08:30 - 10:30
ENDOCRINE AND METABOLIC DISEASES: IMPACT ON WOMEN'S HEALTH
S. Skouby 
Diabetes Mellitis
A. Pines 
Cardiovascular disease and women's health
G.P. Chrousos 
Adrenal disorders
A. Pinchera 
Thyroid disease and pregnancy
11:00 - 13:00
POLYCYSTIC OVARI SYNDROME
J.F. Strauss III 
PCOS: molecular clues to pathophysiology
A. Dunaif 
Genes and enviroment in the pathogenesis of PCOS
A. Lanzone 
Evaluation of clinical, biochemical and ultrasound parameters for the polycystic ovarian syndrome's diagnosis
A. Milewicz 
Plasma adioponectin and resistin levels in obese PCO women: the effect of metoformin treatment
J.E. Nestler 
Polycystic ovary syndrome (PCOS) and insulin resistance: implication for treatment of infertility
 

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali
Tuttocongressi ©1995 - 2025 | Via Dei Perfetti Ricasoli, 94-96 - 50127 Firenze  |  P.Iva 03755090481